Yandong Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yandong Wang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
Can Li
Key Laboratory for Liquid-Solid Structural Evolution & Processing of Materials (Ministry of Education), School of Materials Science and Engineering, Shandong University, Jinan, 250061, Shandong, P. R. China
1 shared publication- Chengwei Wang
Department of Neurosurgery, The Second Qilu Hospital of Shandong University, Jinan, People's Republic of China
1 shared publication Fucheng Gao
Department of Neurosurgery, The Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan, 250031, P.R. China
1 shared publicationJia Meng
Key Laboratory for Liquid-Solid Structural Evolution & Processing of Materials (Ministry of Education), School of Materials Science and Engineering, Shandong University, Jinan, 250061, Shandong, P. R. China
1 shared publicationLei Yu
Key Laboratory for Liquid-Solid Structural Evolution & Processing of Materials (Ministry of Education), School of Materials Science and Engineering, Shandong University, Jinan, 250061, Shandong, P. R. China
1 shared publicationShuai Wang
Key Laboratory for Liquid-Solid Structural Evolution & Processing of Materials (Ministry of Education), School of Materials Science and Engineering, Shandong University, Jinan, 250061, Shandong, P. R. China
1 shared publication
Latest Publications
- Open Access
- 18 April 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Augmenting the catalytic activity of ADzymes: strategic engineering from atomic structure design to macro-environmental interaction for enhanced biomedical efficacy
Nanozymes with atomically dispersed metal sites (ADzymes), characterized by well-defined active centers, high catalytic efficiency, and tunable catalytic properties, have expanded the horizons for developing bio-inspired solutions to address critical challenges in healthcare domains. Herein, this article systematically reviews the synthesis and characterization methods, and classification system of ADzymes, and summarizes the strategies to enhance their catalytic activity ranging from micro- to macro-scales. Key strategies discussed include the biomimetic design of metal active centers, modulation of coordination environments, support interface engineering, and external-field-responsive dynamic activation. Furthermore, the potential applications of ADzymes in ROS-mediated biomedical therapies are highlighted. Based on the systematic deconstruction of the structure-activity relationship, this review provides a theoretical foundation for the rational design of high-performance artificial enzymes. Finally, the current bottlenecks and future perspectives regarding the regulation of ADzymes for clinical translation are discussed, providing insights into their evolution from empirical screening to intelligent design.
- 18 April 2026
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 24 (1)
Open AccessAugmenting the catalytic activity of ADzymes: strategic engineering from atomic structure design to macro-environmental interaction for enhanced biomedical efficacy
Nanozymes with atomically dispersed metal sites (ADzymes), characterized by well-defined active centers, high catalytic efficiency, and tunable catalytic properties, have expanded the horizons for developing bio-inspired solutions to address critical challenges in healthcare domains. Herein, this article systematically reviews the synthesis and characterization methods, and classification system of ADzymes, and summarizes the strategies to enhance their catalytic activity ranging from micro- to macro-scales. Key strategies discussed include the biomimetic design of metal active centers, modulation of coordination environments, support interface engineering, and external-field-responsive dynamic activation. Furthermore, the potential applications of ADzymes in ROS-mediated biomedical therapies are highlighted. Based on the systematic deconstruction of the structure-activity relationship, this review provides a theoretical foundation for the rational design of high-performance artificial enzymes. Finally, the current bottlenecks and future perspectives regarding the regulation of ADzymes for clinical translation are discussed, providing insights into their evolution from empirical screening to intelligent design.